Search Results for: TP53

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CSNK2B casein kinase 2 beta
  • Synthesis of PC
  • WNT mediated activation of DVL
  • Condensation of Prometaphase Chromosomes
  • Signal transduction by L1
  • Neutrophil degranulation
  • Regulation of TP53 Activity through Phosphorylation
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
  • Receptor Mediated Mitophagy
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
  • Regulation of PTEN stability and activity
  • ATP
  • Quercetin
EGLN3 egl-9 family hypoxia inducible factor 3
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ascorbic acid
  • Roxadustat
FOS Fos proto-oncogene, AP-1 transcription factor subunit
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated MAPK activation
  • Activation of the AP-1 family of transcription factors
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • Estrogen-dependent gene expression
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Pseudoephedrine
  • Nadroparin
HMGB1 high mobility group box 1
  • Apoptosis induced DNA fragmentation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Regulation of TLR by endogenous ligand
  • Neutrophil degranulation
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • TRAF6 mediated NF-kB activation
  • Chloroquine
  • Ethyl pyruvate
KAT5 lysine acetyltransferase 5
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • DNA Damage/Telomere Stress Induced Senescence
  • HATs acetylate histones
  • HDR through Single Strand Annealing (SSA)
  • HDR through Homologous Recombination (HRR)
  • Sensing of DNA Double Strand Breaks
  • Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Resolution of D-loop Structures through Holliday Junction Intermediates
  • Nonhomologous End-Joining (NHEJ)
  • Homologous DNA Pairing and Strand Exchange
  • Processing of DNA double-strand break ends
  • Presynaptic phase of homologous DNA pairing and strand exchange
  • Regulation of TP53 Activity through Phosphorylation
  • G2/M DNA damage checkpoint
  • Estrogen-dependent gene expression
  • Coenzyme A
  • S-Acetyl-Cysteine
MYC MYC proto-oncogene, bHLH transcription factor
  • Transcription of E2F targets under negative control by DREAM complex
  • NOTCH1 Intracellular Domain Regulates Transcription
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • MAPK6/MAPK4 signaling
  • Ub-specific processing proteases
  • Interleukin-4 and Interleukin-13 signaling
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • RUNX3 regulates WNT signaling
  • Estrogen-dependent gene expression
  • Transcriptional regulation of granulopoiesis
  • Acetylsalicylic acid
  • Nadroparin
  • Choriocarcinoma
  • Penile cancer
  • Burkitt lymphoma
  • Oral cancer
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Multiple myeloma
  • Small cell lung cancer
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
  • Osteosarcoma
  • Kaposi's sarcoma
  • Laryngeal cancer
  • Breast cancer
  • Ovarian cancer
PHB prohibitin
  • RAF activation
  • Signaling by moderate kinase activity BRAF mutants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Processing of SMDT1
  • Signaling downstream of RAS mutants
  • Rocaglamide
  • Didesmethylrocaglamide
PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1
  • ISG15 antiviral mechanism
  • RHO GTPases Activate NADPH Oxidases
  • Regulation of TP53 Activity through Phosphorylation
  • PI5P Regulates TP53 Acetylation
  • Negative regulators of DDX58/IFIH1 signaling
  • Beta-(2-Naphthyl)-Alanine
  • 3,6,9,12,15,18-HEXAOXAICOSANE
PPIB peptidylprolyl isomerase B
  • Collagen biosynthesis and modifying enzymes
  • Proline
  • 1,4-Dithiothreitol
  • Osteogenesis imperfecta
PRKD1 protein kinase D1
  • Sphingolipid de novo biosynthesis
  • Bryostatin 1
  • Fostamatinib
PRKDC protein kinase, DNA-activated, catalytic subunit
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Caffeine
  • SF1126
RAD51 RAD51 recombinase
  • HDR through Single Strand Annealing (SSA)
  • HDR through Homologous Recombination (HRR)
  • Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
  • Resolution of D-loop Structures through Holliday Junction Intermediates
  • Homologous DNA Pairing and Strand Exchange
  • Presynaptic phase of homologous DNA pairing and strand exchange
  • Transcriptional Regulation by E2F6
  • Meiotic recombination
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Amuvatinib
RB1 RB transcriptional corepressor 1
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Condensation of Prophase Chromosomes
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
  • Cyclin E associated events during G1/S transition
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • RUNX2 regulates osteoblast differentiation
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
  • Defective translocation of RB1 mutants to the nucleus
  • Replication of the SARS-CoV-1 genome
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Replication of the SARS-CoV-2 genome
  • Insulin human
  • Insulin pork
  • Bladder cancer
  • Small cell lung cancer
  • Glioma
  • Osteosarcoma
  • Breast cancer
  • Esophageal cancer
  • Hepatocellular carcinoma
  • Chronic myeloid leukemia (CML)
RELA RELA proto-oncogene, NF-kB subunit
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Regulated proteolysis of p75NTR
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • Transcriptional regulation of white adipocyte differentiation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Interleukin-1 processing
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • CD209 (DC-SIGN) signaling
  • CLEC7A/inflammasome pathway
  • The NLRP3 inflammasome
  • Transcriptional Regulation by VENTX
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • Purinergic signaling in leishmaniasis infection
  • Dimethyl fumarate
  • SC-236
RPS6KA1 ribosomal protein S6 kinase A1
  • ERK/MAPK targets
  • CREB phosphorylation
  • Senescence-Associated Secretory Phenotype (SASP)
  • Senescence-Associated Secretory Phenotype (SASP)
  • Recycling pathway of L1
  • CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • RSK activation
  • RSK activation
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Purvalanol A
  • Fostamatinib
RPS6KA3 ribosomal protein S6 kinase A3
  • ERK/MAPK targets
  • CREB phosphorylation
  • Senescence-Associated Secretory Phenotype (SASP)
  • Senescence-Associated Secretory Phenotype (SASP)
  • Recycling pathway of L1
  • CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
  • RSK activation
  • RSK activation
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Acetylsalicylic acid
  • Fostamatinib
  • Non-syndromic X-linked mental retardation
  • Coffin-Lowry syndrome (CLS)
S100A4 S100 calcium binding protein A4
  • Trifluoperazine
  • Copper
TEC tec protein tyrosine kinase
  • Signaling by SCF-KIT
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Fostamatinib
  • Zanubrutinib
TK1 thymidine kinase 1
  • G1/S-Specific Transcription
  • Pyrimidine salvage
  • Dithioerythritol
  • Thymidine 5'-triphosphate
TOP1MT DNA topoisomerase I mitochondrial
  • Irinotecan
  • Topotecan

Page 6 out of 25 pages